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Naval Research Laboratory, Washington DCABSTRACT Localized surface plasmon resonance (LSPR) imaging has the potential to map complex spatio-temporal varia-
tions in analyte concentration, such as those produced by protein secretions from live cells. A fundamental roadblock to the real-
ization of such applications is the challenge of calibrating a nanoscale sensor for quantitative analysis. Here, we introduce a new,
to our knowledge, LSPR imaging and analysis technique that enables the calibration of hundreds of individual gold nanostruc-
tures in parallel. The calibration allowed us to map the fractional occupancy of surface-bound receptors at individual nanostruc-
tures with nanomolar sensitivity and a temporal resolution of 225 ms. As a demonstration of the technique’s applicability to
molecular and cell biology, the calibrated array was used for the quantitative LSPR imaging of anti-c-myc antibodies harvested
from a cultured 9E10 hybridoma cell line without the need for further purification or processing.INTRODUCTIONThe use of the localized surface plasmon resonance (LSPR)
observed in metallic nanostructures for label-free bio-
sensing is relatively recent but its applicability has already
proven to be far reaching. Early studies were primarily proof
of principle, demonstrating techniques that had the sensi-
tivity to detect the binding of well-characterized receptor-
ligand pairs such as streptavidin and biotin (1–6). More
applied studies followed, such as the detection of liposomes
and Alzheimer’s-related antibodies (7–9). The applications
have grown in sophistication such that LSPR has now
been applied to plasma-enhanced enzyme-linked immuno-
sorbent assay (ELISA) (10), interferometry-based bio-
sensing (11), cell-based assays (12), and the measurement
of protein conformational changes (13) to name a few
(14–19).
Advances in instrumentation and analysis now allow for
many of these measurements to be made on individual nano-
structures, opening the door for new imaging applications in
which hundreds or thousands of nanostructures are
measured in parallel (10,20,21). Thus, LSPR imaging has
the potential to take advantage of each sensor’s nanoscale
dimensions to map complex spatio-temporal variations in
analyte concentration, such as those encountered in live-
cell applications (22,23). In particular, this technique is
well suited for measuring protein secretions from individual
cells. Such secretions play a critical role, for example, in
wound healing (24,25), immune response (26,27), and the
building of the extracellular matrix (28). Patch clamp and
electrode probe measurements also map out secretions
from individual cells but are limited to those moleculesSubmitted August 14, 2012, and accepted for publication November 26,
2012.
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0006-3495/13/01/0030/7 $2.00that are readily oxidized (i.e., neurotransmitters) (22). As
a binding affinity-based technique, LSPR imaging would
be able to measure molecular secretions, which are inacces-
sible to such electrical current-based probes while retaining
the advantage of being label free. As such, these nanoplas-
monic sensors are potentially the next generation of
biophysical instruments for quantitative single-cell secre-
tion measurements.
Before such applications can be realized, fundamental
questions regarding the capabilities of LSPR imaging
must be answered. First, what are the limits of detection
in terms of time, space, and analyte concentration? Here,
we demonstrate a new, to our knowledge, LSPR imaging
technique capable of detecting antibody concentrations on
the order of 1 nM with a spatial resolution determined by
the size of a single nanostructure and with a temporal reso-
lution of 225 ms. Second, we asked whether these results
could be quantified and interpreted to give meaningful
biophysical insight. We show that indeed individual nano-
structures can be calibrated to determine the time-dependent
fractional occupancy of surface-bound receptors, f(t). The
fractional occupancy is a key parameter in the quantitative
analysis of analyte binding in that once known it can be
used to determine kinetic rate constants if the concentration
of analyte is known or, conversely, for determining concen-
tration if the rate constants are known.
The key features of our design are 1), the fabrication of
the arrays by electron beam lithography for the production
of highly uniform nanostructures, as confirmed by both
size and spectral characterizations; 2), the simultaneous
measurement of spectra and imagery; and 3), the combina-
tion of the spectral and imagery data into an analysis
formalism that enables the determination of f(r,t), where r
denotes the location on the substrate. It is important to
note that the calibration takes place in an imaging, or batchhttp://dx.doi.org/10.1016/j.bpj.2012.11.3821
Quantitative LSPR Imaging 31mode, which allows for simultaneous data collection over an
entire array of nanostructures. This is essential because the
sequential calibration of hundreds or thousands of indi-
vidual nanostructures is time consuming and impractical.
Using an array of 400 nanostructures, we first demon-
strate that our technique allows for the qualitative detection
of commercially available anti-c-myc antibodies with single
nanostructure resolution using only a charge-coupled device
(CCD) camera. Using the same array of nanostructures, we
then detail the calibration methodology that enables the
quantification of the CCD-based measurements for the
determination of f(r,t). As a demonstration of the technique’s
applicability to molecular and cell biology, the calibrated
array was used for quantitative LSPR imaging of anti-c-
myc antibodies that were harvested from the hybridoma
cell line 9E10 without the need for their further purification
or processing. All experiments were conducted in the same
serum-free medium (SFM) used for cell culturing
applications.EXPERIMENTAL SECTION
Fabrication and functionalization of the
nanostructures
The arrays of nanostructures were fabricated on No. 1.5,
25 mm diameter borosilicate glass coverslips by electron-
beam lithography (EBL) (20). The bases of the nano-
structures were circular in cross section with diameters of
70 5 5 nm and the heights were 75 5 2 nm. Each square
array consisted of 400 nanostructures (20  20) with a
spacing of 400 nm between nanostructures. The chip was
cleaned by plasma ashing in 5% hydrogen, 95% argon
mixture, and then functionalized by immersion in a two-
component thiol solution (0.5 mM), consisting of a 3:1
ratio of SH-(CH2)8-EG3-OH (SPO)/SH-(CH2)11-EG3-NH2
(SPN), for 18 h (Prochimia, Sopot, Poland) (29). The SPN
component of the self-assembled monolayer (SAM) was
first reacted with a 10 mg/mL solution of the heterobifunc-
tional cross-linker sulfo-N-succinimidyl-4-formylbenza-
mide (Sulfo-S-4FB, Solulink, San Diego, CA) in 100 mM
phosphate buffered saline (100 mM PBS, Thermo Scientific,
Rockford, IL) and then conjugated to the c-myc peptide
(HyNic-c-myc-tag, Solulink) according to the manufac-
turer’s instructions. Anti-c-myc secreting hybridoma cells
(MYC1-9E10.2, ATCC, Manassas, VA) were adapted to
growth in SFM containing 1% antibiotic/antimycotic by
the sequential, stepwise reduction in fetal bovine serum
(BSA) content over a 1-month culture period. The secretion
of the 9E10.2 monoclonal antibodies (anti-c-myc) was
confirmed and quantified by ELISA using a BSA-c-myc
peptide conjugate (~7 c-myc peptides per BSA) as the
immobilized antigen (coated overnight at 5 mg/mL in
100 mM PBS at 4C). The details of the nanostructure fabri-
cation by EBL, plasma ashing procedure, and applicationof the SAM layer have been previously described (20).
Additional information on the materials used, chip
functionalization procedures, hybridoma culturing, and the
ELISA assay can be found in the Supporting Material.Optical setup
CCD-based LSPR imaging, as well as LSPR spectra, was
collected in a reflected light geometry with an inverted
Zeiss microscope using Koehler illumination, an infinity-
corrected 63X, 1.4 numerical aperture oil-immersion
objective and crossed polarizers to reduce the background
contribution from substrate-scattered light. Imagery and
spectra were obtained simultaneously by placing a beam
splitter at the output port of the microscope (Fig. 1 a) and
a longpass filter with a 593 nm cutoff wavelength was
placed before the CCD camera. For the spectral measure-
ments, the focused image of the entire nanostructure array
was projected on to the end of a 600 mm diameter optical
fiber and the spectra were subsequently measured with
a thermoelectrically cooled, CCD-based spectrophotometer
(QE65000, Ocean Optics, Dunedin, FL). The spectropho-
tometer integration time was 4 s. For image acquisition,
the focused image of the array was projected onto a thermo-
electrically cooled CCD camera with 6.45  6.45 mm sized
pixels (ORCA R2, Hamamatsu, Bridgewater, NJ) and
a frame integration time of 225 ms. Details of how the
previous setup was optimized for high contrast imaging
of the gold nanostructures are described elsewhere (20).
Analyte was introduced under continuous flow conditions
using a custom-made microfluidic cell at a flow rate of
10 mL/min. The microscope stage was equipped with a
temperature-controlled insert, which kept the stage temper-
ature and optical light train at 28.0 5 0.04C (PeCon
GmbH, Erbach, Germany). Under these conditions, the
drifts in the x, y, and z directions were <3 nm/min. For
data analysis, all frames were aligned in x and y using a
commercially available image processing alignment algo-
rithm (Axiovision, Zeiss, Thornwood, NY).RESULTS AND DISCUSSION
Qualitative biosensing with single
nanostructures
The imagery as well as LSPR spectra were simultaneously
acquired by passing the reflected light through a 50/50
beam splitter as shown in Fig. 1 a. Fig. 1 b shows two
spectra from a specific binding study in which 200 nM of
anti-c-myc was introduced over a c-myc functionalized
array at a flow rate of 10 mL/min. The finitial spectrum
(black) was taken before the anti-c-myc was introduced
and the ffinal spectrum (red) was taken after 1 h of exposure.
The characteristic red shift of the peak position and the cor-
responding increase in counts from 605 to 750 nm areBiophysical Journal 104(1) 30–36
FIGURE 1 (a) Imaging and spectroscopy setup in which P1 and P2 are crossed polarizers, BS is a 50/50 beam splitter and LP is a longpass filter with
a 593 nm cutoff. The inset shows an atomic force microscopy scan of a witness array fabricated on the same chip. (b) Two spectra from a specific binding
study in which 200 nM of anti-c-myc was introduced over the c-myc functionalized array (10 mL/min). The finitial spectrum (black) was taken before the anti-
c-myc was introduced and the ffinal spectrum (red) after 1 h of exposure. (c) Normalized spectra from 18 individual nanostructures taken in air on a separate
darkfield microspectroscopy setup. Individual spectra are superposed (gray curves) and compared to the ensemble average (black curve).
32 Raphael et al.indicative of a local change in the dielectric constant of
the medium caused by the specific binding of the anti-c-
myc antibody (1,13). Although monitoring the peak
shift is currently the most common method of detecting
analyte binding, we have shown (20) that it is the increase
in the scattered intensity over such a large portion of
the resonance spectrum that allows for the fractional occu-
pancy of the array to be determined spectroscopically, while
simultaneously enabling LSPR imaging via the CCD
camera.
The calibration of hundreds of nanostructures in batch
mode requires that the spectral properties of individual
nanostructures closely resemble that of the array ensemble
average. Topological studies of our nanostructures by
atomic force microscopy revealed small variations in nano-
structure shape, particularly with regards to the surface
roughness at the tips of the nanostructures (Fig. 1 a, inset).
To investigate the corresponding spectral variations among
individual nanostructures, a separate setup designed for
single-nanostructure spectroscopy (based on darkfield mi-
crospectroscopy) was used for characterizing a witness
row of 18 nanostructures fabricated on the same chip as
the array used for biosensing. The data were collected in
air, which accounts for the fact that the resonance peaks
are blue shifted relative to those in Fig. 1 b, which were
collected in SFM. Further details of this technique are given
in the Supporting Material. The results, summarized inBiophysical Journal 104(1) 30–36Fig. 1 c, show that although small variabilities in the shape,
amplitude, and resonant wavelength could be discerned, the
spectrum of nearly every nanostructure fell close to the
ensemble average. In the CCD imagery, these distributions
can be manifested as a distribution of intensities, as shown
in the Fig. 2 insets, which have been contrast enhanced to
highlight the intensity variations.
In Fig. 2, we detail the time course of a 200 nM anti-c-
myc specific binding study as measured by LSPR imagery
and demonstrate a straightforward image analysis technique
for qualitatively monitoring the kinetics down to the single
nanostructure. Fig. 2 a shows the enhanced counts from
binding for the entire array (84  84 pixels) as calculated
from the mean intensity of the pixels bounded within the
light blue region of interest (ROI) square:
Iðri; tnÞ ¼ 1
mi
X
~x˛ri
Iimageð~x; tnÞ; (1)
wheremi is the number of pixels in the ROI denoted as ri and
tn is the time point. Also shown is a drift study that preceded
the introduction of analyte (black circles) in which SFM
flowed over the array for 30 min at 10 mL/min. In contrast
to simple buffers, SFM typically contains anywhere from
50 to 1000 mg/L of additional proteins such as albumin,
transferrin, and insulin, which can potentially biofoul the
sensors. Despite this presence, our measurements showed
FIGURE 2 LSPR imaging time-course measurement from a 200 nM
anti-c-myc specific binding study. (a) Mean intensity for the entire array
(square light blue ROI, 84 84 pixels) (b) Mean intensity of a single nano-
structure (square red ROI, 4  4 pixels). (c) Comparison of the normalized
responses of the whole array and the single nanostructure. Also plotted in
(a) and (b) are the results of a drift study that preceded the introduction
of analyte (black circles). The inset images in (a) and (b) shows
a contrast-enhanced CCD image of the 8  8 mm array that highlights
the variations in nanostructure intensities. All studies were conducted in
SFM at a flow rate of 10 mL/min.
FIGURE 3 LSPR imaging time-course measurement from a 70 nM anti-
c-myc specific binding study. Time course plots from five representative
nanostructures coplotted with the response of the entire array. The insets
show a contrast-enhanced CCD image of the array in which the five nano-
structures are outlined by the red box. The nanostructures are labeled A–E
from left to right in the image. The study was conducted in SFM at a flow
rate of 10 mL/min.
Quantitative LSPR Imaging 33minimal drift and sensitivity to analyte that was retained.
Additional studies showing minimal nonspecific binding
studies between the antibody and the SAM-functionalized
surface were conducted using a Bio-Rad XPR36 surface
plasmon resonance instrument and are presented in the Sup-
porting Material. In these studies, we compared the signal
from the nonspecific binding of c-myc blocked anti-c-myc
to the specific binding signal given by unmodified anti-c-
myc (control). The blocked anti-c-myc gave a signal of
1% or less compared to its corresponding control study
(Fig. S3), thus showing minimal nonspecific binding.
Fig. 2 b plots the same two experiments but with the ROI
now composed of only a single nanostructure, as selected by
a 4  4 pixel (410  410 nm) square ROI shown in red near
the center of the array. The relative response of the nano-
structure is compared directly to that of the entire array in
Fig. 2 c by plotting the normalized counts:½Iðri; tnÞ  Iðri; toÞ
I

ri; tf
 Iðri; toÞ;
where Iðri; toÞ is the average of the first 20 time points and
Iðri; tf Þ is the average of the last 20 time points. This same
straightforward ROI approach can be applied to any nano-
structure in the array, giving 400 independent and label-
free nanosensors within the 8  8 mm area. A separate
specific binding experiment in which 70 nM of anti-c-myc
was introduced over c-myc functionalized gold nanostruc-
tures is shown in Fig. 3. This figure highlights the distribu-
tion in the normalized response of individual nanostructures
about that of the entire array by plotting the response of five
representative nanostructures within the array. The five
nanostructures are indicated in the inset CCD image by
a red box and labeled A–E from left to right.
Fig. 2 c and Fig. 3 highlight a key observation in this
work, namely, that the response within the nanoscale ROIs
are typically in excellent agreement with that of the entire
array. Thus, if the entire array can be calibrated for the deter-
mination of the fractional occupancy, f(t), this homogeneous
response in principle can be used to simultaneously calibrate
the individual nanostructures. This at first can seem
surprising given the likelihood that the surface-bound recep-
tors on any given nanostructure will have an inhomogeneous
spatial distribution and response to analyte (30,31). It is
reasonable, however, given that both the theory of random
sequence adsorption (32) and experimental estimates using
similarly functionalized gold surfaces (10,33) are in agree-
ment that nanostructures of this size can accommodate
hundreds of proteins, thus averaging out the effect of such
inhomogeneities. We now discuss how this qualitative
observation can be expanded into a data analysis formalism,
which allows for the quantitative determination of the frac-
tional occupancy within the imagery.Biophysical Journal 104(1) 30–36
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We have previously reported (20) a methodology that allows
for the determination of the fractional occupancy of the entire
array from the spectral data, denoted here as fSðtÞ. In short,
the number of counts at wavelength, l, accumulated by the
spectrometer during the time interval tn can be written
as a linear response model with Poisson counting noise,
hPoisson, in terms of the fS for a specifically bound monolayer
perturbing the localized surface plasmon resonance:
NlðtnÞ ¼ gðtnÞ$½al fSðtnÞ þ bl þ hPoisson: (2)
The model parameters al and bl represent the wavelength-
dependent dielectric response caused by the bound analyte
and the initial background of the LSPR array, respectively.
The overall time-dependent coefficient, gðtnÞ, is initially
set to one at the beginning of the experiment but can
account for drift and jump processes that cause variations
in the scattered light intensity with no wavelength depen-
dence. Generally, gðtnÞz1 and can be ignored in most situ-
ations. For a given nanostructure array and experimental
conditions the bl is determined when no analyte is present
at the beginning of the experiment and the al is determined
by a saturating injection of a known concentration of analyte
at the end of the experiment. The time-dependent functions
gðtnÞ and fSðtnÞ can be determined by nonlinear regression
within a Poisson noise model for the counts at each time
interval, tn.
The question of interest in this study is whether the
imagery of single nanostructures can encode the same infor-
mation as the ensemble measurement of the entire array as
measured spectroscopically. In other words, if the array is
subjected to a uniform spatial distribution of analyte, can
we calibrate the optical response of nanostructure-sized
ROIs to that of the ensemble fractional occupancy found
by spectroscopy? It is not obvious that this should be
possible because the image sums up all the spectral informa-
tion and individual nanostructures can be subject to
stochastic processes that average away when the entire array
is used. To assess whether the imagery of single nanostruc-
tures can capture the fractional occupancy information
found in whole-array spectroscopy, we propose a simple
generative model for how the image data is formed, similar
to that used in analyzing the spectroscopy data:
Iðri; tnÞ ¼ AðriÞ$fIðri; tnÞ þ BðriÞ þ hPoisson: (3)
Here, the model parameters al and bl are analogously
represented by the spatially dependent parameters AðriÞ
and BðriÞ for the determination of the fractional occupancy
from the image data, fIðri; tnÞ. Because the size of the array
is small compared to the diffusion length of the analyte over
the exposure time of the CCD camera, the concentration is
effectively uniform. This allows us to determine AðriÞ and
BðriÞ via multivariate linear regression (see the SupportingBiophysical Journal 104(1) 30–36Material for details) by setting fIðri; tnÞ ¼ fSðtnÞ, thus, cali-
brating the entire array via imagery. Once the array is cali-
brated, inhomogeneous fractional occupancy can be
estimated as
bf Iðri; tnÞ ¼ Iðri; tnÞ  BðriÞAðriÞ : (4)
To determine if this relatively simple treatment of the
imagery data is effective, we can calculate the variance in
the local response, bf Iðri; tnÞ, of the nanostructure array
from fSðtnÞ over the ROIs:
s2ðriÞ ¼ 1
N
XN
n¼ 1
 bf Iðri; tnÞ  fSðtnÞ
2: (5)
The resulting image map will show what parts of the array
are capable of being calibrated for the determination of
the local fractional occupancy.
As an example of the applicability of this approach to
molecular and cell biology, we demonstrate the determina-
tion of fractional occupancy versus time at the nanoscale
to the secreted antibodies contained within the supernatant
of cultured MYC1-9E10.2 hybridoma cells. The harvested
antibodies experiment was conducted by simply centri-
fuging the cells at 3000 rpm for 5 min, collecting the super-
natant and applying that solution to the nanostructures via
the microfluidic setup at a flow rate of 10 mL/min. The
concentration of secreted anti-c-myc antibodies in the
supernatant was independently determined by ELISA to
be 9 nM. The nanostructure calibration was conducted
as described previously by introducing a known concentra-
tion of commercial anti-c-myc (250 nM) over the nano-
structures immediately following the harvested antibody
experiment.
Fig. 4 displays the BðriÞ and AðriÞ response maps of
a 12.4  12.4 mm area centered about the array for every
pixel in the image (ROI: 1  1 pixel). A grid of 4  4 pixel
(410  410 nm) squares has been superimposed over each
map to demarcate the location of each nanostructure from
the imagery. In Fig. 4 a, the dark red regions of the coeffi-
cient map for the background term, BðriÞ, are highly corre-
lated with the brightest nanostructures in the CCD image
(Fig. 2, inset), as is to be expected for the background contri-
bution to the fit. The coefficient map for the linear response
term, AðriÞ, is shown in Fig. 4 b. Again the strongest positive
responses are located within the squares of the grid and thus
are correlated with the locations of the nanostructures. We
then repeated the optimization using a sliding ROI window
of the same size as the grid (4  4 pixels), which had the
advantage of closely approximating the size of the diffrac-
tion-limited image of the nanostructures. In addition, this
larger ROI averaged out the presence of a slight drift of
~2 pixels (1.7 nm/min), which occurred over the course of
the 2 h run.
FIGURE 4 (a) Background response map, BðriÞ, and (b) linear response
map, AðriÞ, of the array for the anti-c-myc harvested antibody study, calcu-
lated for every pixel in the image (ROI: 1  1 pixel). The calibration was
conducted immediately following the harvested antibody study by injecting
250 nM of commercial anti-c-myc in SFM. A grid of 4  4 pixel squares
has been superimposed to demarcate the location of the nanostructures in
the imagery.
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analysis are summarized in Fig. 5. Fig. 5 a shows the error
estimate map of si, which presents the deviations between fI
and fS as a grayscale map. The shape of the array is clearly
reproduced on the map because it is only within the array
area that fI and fS are within reasonable agreement. In
fact, by setting the scale of si on the map to be between
0 and 0.1 we show that over 75% of the area encompassed
by the array can be well calibrated with the spectroscopi-
cally determined fractional occupancy. To illustrate the
deviations between fI and fS associated with a given si,
the data from specific ROIs are plotted in Figs. 5, b–e,
with si ¼ 0:03, si ¼ 0:05, si ¼ 0:10, and si ¼ 0:42, respec-
tively. The color of the ROI data points are matched with
that of the ROI square label on the response map and the
vertical dashed line indicates the end of the harvested
anti-c-myc antibody run, at which point 250 nM of commer-
cial anti-c-myc was injected. There is excellent agreement
between the two for si%0:05 (red and green ROIs), which
deteriorates somewhat at si ¼ 0:1 (dark blue ROI), whereas
there is no statistically meaningful correlations for the light
blue ROI located outside of the array.CONCLUSIONS
The results in Fig. 5 show that for the majority (over 75%) of
the array, fI can be determined to within 10% of fS using
ROIs of a similar size to that of the diffraction-limited image
of each nanostructure. Even with the reproducibility of
fabricating by EBL, however, it was not possible to calibrate
the entire array area to within this range of error. This is not
an impediment though because a great advantage to our
approach is that those ROIs, which do not calibrate to within
a set specification can simply be ignored, whereas those that
do can be used for the quantitative analysis. As such, our
LSPR imaging technique allows for label-free and quantita-
tive characterization of cell supernatant with minimal prep-
aration and nanomolar sensitivity, using hundreds of
nanostructures independently calibrated to within the user’s
specification. In its current form, this technology sets the
stage for future applications in high density proteomics
arrays as well as for imaging analyte concentration gradients
in complex live cell environments. Future work will focus
on implementing a nonprotein-based calibration procedure
by using more easily replaced mixtures of glycerol and
water (34) and the inclusion of nonlinear terms in the
analysis.SUPPORTING MATERIAL
Supporting figures, equations, materials, and methods are available at http://
www.biophysj.org/biophysj/supplemental/S0006-3495(12)05068-0.
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